Webinar: The Epigenetics Approach to Driving Cell Identity and Scalability in Cell Therapy
In the delivery of scalable cell therapies, there is a fundamental need to derive viable cells in vitro. In addition to developing cell cultures that mimic in vivo conditions for the maintenance of target cell types, cells need to acquire and develop specific therapeutic characteristics. How can epigenetics and innovative computational approaches, such as epiMOGRIFY, be implemented to drive cell identity and scalability in cell therapy?
Featuring panelists Dr. Zoe Hewitt (UK Regenerative Medicine Platform), Dr. Owen Rackham (Duke-NUS Medical School) and Dr. Rodrigo Santos (Mogrify), this webinar-on-demand discusses:
• The challenges associated with the cGMP manufacture of efficacious and scalable cell therapies.
• Leveraging the power of epigenetics to drive and maintain cell identity.
• How systematic data-driven approaches, such as epiMOGRIFY, can be implemented to enhance directed differentiation or cell conversion under cGMP-compliant cell manufacturing to support the development of scalable off-the-shelf therapies.